Chairman Of Council, Daystar University
Current
Jul 2022 - Present
AeroLeads people directory · profile
F. George Njoroge Email & Phone Number
Founder and Chairman of Center of Africa’s Life Sciences (C.O.A.L.S)
at
Daystar University
1 work email found
@msn.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Founder and Chairman of Center of Africa’s Life Sciences (C.O.A.L.S)
Location
Nairobi County, Kenya, Kenya
Who is F. George Njoroge? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
F. George Njoroge is listed as Founder and Chairman of Center of Africa’s Life Sciences (C.O.A.L.S) at Daystar University, based in Nairobi County, Kenya, Kenya. AeroLeads shows a work email signal at msn.com and a matched LinkedIn profile for F. George Njoroge.
F. George Njoroge previously worked as Chairman of Council, Daystar University at Daystar University and Chief Scientific Advisor, KUTRRH at Kenyatta University Teaching Referral And Research Hospital. F. George Njoroge holds Phd, Organic Chemistry from Case Western Reserve University.
Company email context
Email format at Daystar University
This section adds company-level context without repeating F. George Njoroge's masked contact details.
*@msn.com
68% confidence
AeroLeads found 1 current-domain work email signal for F. George Njoroge. Compare company email patterns before reaching out.
Profile bio
About F. George Njoroge
Inducted to "Hall of Fame" as a 2012 ACS Hero of chemistry for the discovery of Victrelis, the first Hepatitis C virus protease inhibitor approved by FDADirected discoveries of hepatitis C drugs Victrelis™ (BOCEPREVIR®) that was approved by FDA on May 13th 2011 as the first HCV protease inhibitor and NARLAPREVIR® a second generation HCV protease drug licensed to a Russian company, R-Phama. Spearheaded the discovery of the anti-cancer drug SARASAR®, this drug was approved on the 24th of November 2020 as Zokinvy for the treatment of progeria. Published 104 US granted patents and 136 papers in reputable journals. Received Thomas Alva Edison Patent Award for US patent work on Boceprevir®. Received Emerald Award from Career communication group for leadership excellence in drug discovery.FIRST AFRICAN TO BE GRANTED OVER 100 PATENTS BY US PATENTING AGENCYLink: http://www.mwakilishi.com/content/articles/2012/08/26/a-leading-kenyan-scientist-based-in-the-us-named-a-hero-of-chemistry.htmlSpecialties: Managed collaboration with other institutions, engaged CRO's, active in due diligence efforts, managed expence centre.
Listed skills include Medicinal Chemistry, Drug Discovery, Cro, Clinical Trials, and 46 others.
Current workplace
F. George Njoroge's current company
Company context helps verify the profile and gives searchers a useful next step.
17 roles · 51 years
F. George Njoroge work experience
A career timeline built from the work history available for this profile.
Chief Scientific Advisor, Kutrrh
Current
Kenyatta University Teaching Referral And Research Hospital
Oversee Research grants
Apr 2022 - Present
Commitee Member Of Ontario Institute For Cancer Research Therapeutics Pipeline Advisory Board
Current
Ontario Institute For Cancer Research Therapeutics
Review of scientific research proposals submitted by Canadians in the oncology area
Jan 2021 - Present
Founder And Chairman Of Center Of Africa’S Life Sciences (C.O.A.L.S)
Current
Center Of Africa’S Life Sciences (C.O.A.L.S)
Life Sciences including, research, drug manufacturing, scientific meetings
Jan 2019 - Present
Board Director At Kemri And Chairperson Of Scientific Research And Innovation
Kenya Medical Research Institute(Kemri)
National medical research for innovation and informing policy to Kenyan Ministry of Health
May 2021 - Jul 2023
Board Member Of University Council, Kca University
Oversight in management of university including providing directions in research activities
Jul 2020 - Jun 2023
Chief Scientific Advisor /Ag Director Research, Innovation & Entrepreneurship
Kenyatta University Teaching, Referral And Research Hospital
Innovating New Medical Modalities
Aug 2020 - Aug 2022
Aug 2011 - Dec 2019
Director, Medicinal Chemistry
Direct discovery of medicines in the anti-viral and related areas
Nov 2009 - Nov 2011
Director, Medicinal Chemistry
- Directed a team of twenty chemists towards discovery of the second generation HCV protease inhibitor, Narlaprevir®, (SCH 900518) that is currently in Phase II clinical trials – this molecule is considered to be “the.
- Directed a team of twenty chemists that discovered very potent non nucleoside HCV polymerase inhibitor - SCH 900942 – was advanced to Phase I Clinical trials.
Apr 2005 - Nov 2009
Associate Director, Medicinal Chemistry, Schering-Plough Research Institute
- Directed a team of thirteen chemists in the discovery of the first in class HCV protease inhibitor, Boceprevir® (SCH 503034) that has demonstrated remarkable efficacy in HCV viral load reduction and is currently in.
Apr 2000 - Apr 2005
Senior Principal Scientist
- Headed a group involved in identification of a back-up compound to SARASAR®.
Mar 1996 - Apr 2000
Principal Scientist
- Led the way to the discovery of farnesyl transferase inhibitor, SARASAR® that is currently in Phase II clinical trials for the treatment of Progeria.
Mar 1991 - Mar 1996
Senior Scientist
- Designed and synthesized very potent collagenase IV inhibitors that inhibited metastasis in cancer cells.
Apr 1988 - Apr 1991
Senior Research Associate
- Established major agents involved in cross-linking of proteins in diabetic and aging people. This work provided important bio-markers for evaluating disease progression.
Apr 1987 - Apr 1988
Research Associate
- Established the relevance of the Maillard reaction (browning) in complications associated with diabetes and aging processes
May 1985 - Mar 1987
Fellow
1975 - 1980
~5 yrs
3 education records
F. George Njoroge education
Phd, Organic Chemistry
Bsc, Chemistry
Education record
Thika High School
FAQ
Frequently asked questions about F. George Njoroge
Quick answers generated from the profile data available on this page.
What company does F. George Njoroge work for?
F. George Njoroge works for Daystar University.
What is F. George Njoroge's role at Daystar University?
F. George Njoroge is listed as Founder and Chairman of Center of Africa’s Life Sciences (C.O.A.L.S) at Daystar University.
What is F. George Njoroge's email address?
AeroLeads has found 1 work email signal at @msn.com for F. George Njoroge at Daystar University.
Where is F. George Njoroge based?
F. George Njoroge is based in Nairobi County, Kenya, Kenya while working with Daystar University.
What companies has F. George Njoroge worked for?
F. George Njoroge has worked for Daystar University, Kenyatta University Teaching Referral And Research Hospital, Ontario Institute For Cancer Research Therapeutics, Center Of Africa’S Life Sciences (C.O.A.L.S), and Kenya Medical Research Institute(Kemri).
How can I contact F. George Njoroge?
You can use AeroLeads to view verified contact signals for F. George Njoroge at Daystar University, including work email, phone, and LinkedIn data when available.
What schools did F. George Njoroge attend?
F. George Njoroge holds Phd, Organic Chemistry from Case Western Reserve University.
What skills is F. George Njoroge known for?
F. George Njoroge is listed with skills including Medicinal Chemistry, Drug Discovery, Cro, Clinical Trials, Biomarker Discovery, Patents, Drug Design, and Dmpk.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial